Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries. Read More
The Government of India targets to procure 20 to 25 crore COVID-19 vaccine doses by July-end and 30 crore doses in August-September, informed government sources on Sunday. ...
India should prepare to give one crore COVID-19 jabs a day which will be possible in a few weeks with due preparation and the vaccination should be taken up to 73 doses in the next three weeks, Niti Aayog Member (Health) Dr VK Paul has said. ...
Two days after Serum Institute of India (SII) executive director Suresh Jadhav's controversial remarks on India's vaccination drive against COVID-19, the world's largest vaccine maker completely dissociated itself from the statement and clarified tha ...
BSE Listed BCPL Railway Infrastructure Ltd. (BSE: 542057) announced its Results for Q4 FY21 and FY21 after the meeting of Board of Directors was held. The Board of Directors recommended a Dividend of 0.7 per share (7%) previous year 6%. Total pay-out ...
The Pune-based Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said his firm has "never exported vaccines at the cost of the people of India." ...
The National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended an increase in the gap between two doses of Serum Institute of India's COVISHIELD to 12-16 weeks. ...
